Stock PV3B EYEPOINT PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart EyePoint Pharmaceuticals, Inc. Deutsche Boerse AG

Equities

PV3B

US30233G2093

Real-time Estimate Tradegate
Other stock markets
 01:12:26 2024-06-17 pm EDT 		5-day change 1st Jan Change
8.452 EUR -0.80% Intraday chart for EyePoint Pharmaceuticals, Inc. +3.53% -59.57%
Jun. 12 Transcript : EyePoint Pharmaceuticals, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 03:20 PM
Jun. 04 JPMorgan Adjusts EyePoint Pharmaceuticals Price Target to $32 From $35, Maintains Overweight Rating MT
fc906d3fdb847.TBJWeC8rw4ZXIcU7zJkX2Y4jRWJGf94yToyuNUUhpME.HVkUO35znOsyEI4DitVAmMt8dDYvEpd3Cc_5egxv8fIlUAw6HGG0qxUS_Q~305dcffefc80452077bfcd1a5003c28c
  1. Stock Market
  2. Equities
  3. EYPT Stock
  4. PV3B Stock
  5. Charts EyePoint Pharmaceuticals, Inc.
  6. News Chart